Skip to content

Clinical trials

Phase 3 Respiratory Tract Diseases trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Respiratory Tract Diseases Phase: Phase 3 Country / region: Belgium Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20143
20161
20171
20182
20192
20201
20221
20231
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Recruiting3
Terminated3
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
United Therapeutics2
Bellus Health Inc. - a GSK company1
Daiichi Sankyo1
Eli Lilly and Company1
GlaxoSmithKline1
Hoffmann-La Roche1
Novartis Pharmaceuticals1
Pfizer1
UMC Utrecht1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Respiratory Tract Diseases14
Lung Diseases11
Bronchial Diseases4
Lung Diseases, Obstructive4
Asthma3
Carcinoma, Non-Small-Cell Lung3
Lung Neoplasms3
Neoplasms3
Neoplasms by Site3
Respiratory Tract Neoplasms3

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.